H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.6% of adults in West Valley City have diagnosed diabetes — 1.4 points below the U.S. 12% figure. Census population 140,230. Utah Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed West Valley City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a West Valley City storefront.
Wharton's Jelly Allograft Products in West Valley City, UT for clinics & physicians. Wharton's jelly allog… Compliance support & pricing — contact Hawk Medical.
West Valley City is a city under 250k (140,230 Census). CDC PLACES (2023, crude) estimates 10.6% of adults in West Valley City have diagnosed diabetes — 1.4 points below the U.S. 12% figure. Adult arthritis here is 20.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Wharton's Jelly Allograft Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 10.6% of adults in West Valley City have diagnosed diabetes — 1.4 points below the U.S. 12% figure. Adult obesity in West Valley City is 33.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 20.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JF / Noridian Healthcare Solutions, sibling states AK, AZ, ID, MT, ND, OR, SD, WA, WY. Utah Department of Health & Human Services is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a West Valley City warehouse or a five-star local review. What you get is whartons jelly allograft from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JF, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 10.6% of adults — 1.4 points below the U.S. 12% figure. Obesity is 33.5%; arthritis is 20.9%. That is place-level BRFSS modeling, not a clinic census and not a West Valley City trial.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JF reviewers and surveyors expect — not a brochure.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
This URL is written for healthcare providers shopping distribution. Patient-facing ads must follow your state medical board and FTC rules. Do not copy distributor language into consumer ads that imply guaranteed healing.
If you operate in Utah and another MAC state, say it on the first call. JF will not port 1:1. We would rather split utilization than watch a sister clinic copy West Valley City tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in West Valley City, UT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for West Valley City is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for West Valley City — 1.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Utah Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, OR, SD, WA, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in West Valley City. Useful for joint-program math; still needs a diagnosis and privileging.
No West Valley City storefront. Joe Bradley is an active practice owner. whartons jelly allograft stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.